Ads
related to: pfizer vaccine
Search results
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 3 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 4 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 18 hours agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 5 hours agoThe revision follows the approval of Moderna's Respiratory Syncytial Virus (RSV) vaccine by...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 3 hours agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 4 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
NHS launches personalised mRNA cancer vaccines trial
Clinical Trials Arena via Yahoo Finance· 3 days agoThe company will present preliminary data, highlighting the potential of circulating tumour DNA in the early detection of colorectal cancer. The vaccine...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 3 days agoThe shot was also 68.4% effective against acute respiratory disease. William Blair analyst Myles...
California State Teachers Retirement System Increases Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 6 hours agoCalifornia State Teachers Retirement System grew its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 1.5% during the fourth quarter, according to its most recent 13F filing ...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 3 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...